• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p63/MT1-MMP 轴在基底样乳腺癌原位浸润转移中起关键作用。

p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.

机构信息

Membrane and Cytoskeleton Dynamics Group, Cell Dynamics and Compartmentalization Unit, Institut Curie, Centre National de la Recherche Scientifique UMR144, Paris, France.

Mammalian Developmental Epigenetics Group, Genetics and Developmental Biology Unit, Institut Curie, Paris, France.

出版信息

Oncogene. 2016 Jan 21;35(3):344-57. doi: 10.1038/onc.2015.87. Epub 2015 Apr 20.

DOI:10.1038/onc.2015.87
PMID:25893299
Abstract

The transition of ductal carcinoma in situ (DCIS) to invasive breast carcinoma requires tumor cells to cross the basement membrane (BM). However, mechanisms underlying BM transmigration are poorly understood. Here, we report that expression of membrane-type 1 (MT1)-matrix metalloproteinase (MMP), a key component of the BM invasion program, increases during breast cancer progression at the in situ to invasive breast carcinoma transition. In the intraductal xenograft model, MT1-MMP is required for BM transmigration of MCF10DCIS.com breast adenocarcinoma cells and is overexpressed in cell clusters overlying focal BM disruptions and at the invasive tumor front. Mirrored upregulation of p63 and MT1-MMP is observed at the edge of MCF10DCIS.com xenograft tumors and p63 is required for induction of MT1-MMP-dependent invasive program in response to microenvironmental signals. Immunohistochemistry and analysis of public database reveal that p63 and MT1-MMP are upregulated in human basal-like breast tumors suggesting that p63/MT1-MMP axis contributes to progression of basal-like breast cancers with elevated p63 and MT1-MMP levels.

摘要

导管原位癌 (DCIS) 向浸润性乳腺癌的转变需要肿瘤细胞穿过基底膜 (BM)。然而,BM 迁移的机制尚不清楚。在这里,我们报告膜型 1 (MT1)-基质金属蛋白酶 (MMP) 的表达在原位至浸润性乳腺癌转变过程中在乳腺癌进展过程中增加,MT1-MMP 是 BM 浸润程序的关键组成部分。在腔内异种移植模型中,MT1-MMP 是 MCF10DCIS.com 乳腺腺癌细胞 BM 迁移所必需的,并且在局灶性 BM 破坏上方的细胞簇和浸润性肿瘤前缘过度表达。在 MCF10DCIS.com 异种移植肿瘤的边缘观察到 p63 和 MT1-MMP 的镜像上调,并且 p63 是对微环境信号响应诱导 MT1-MMP 依赖性浸润程序所必需的。免疫组织化学和公共数据库分析表明,p63 和 MT1-MMP 在人基底样乳腺癌中上调,提示 p63/MT1-MMP 轴有助于具有升高的 p63 和 MT1-MMP 水平的基底样乳腺癌的进展。

相似文献

1
p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.p63/MT1-MMP 轴在基底样乳腺癌原位浸润转移中起关键作用。
Oncogene. 2016 Jan 21;35(3):344-57. doi: 10.1038/onc.2015.87. Epub 2015 Apr 20.
2
Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.MT-1基质金属蛋白酶、基质金属蛋白酶2、基质金属蛋白酶9和金属蛋白酶组织抑制因子2 mRNA在乳腺导管原位癌和浸润性导管癌中的表达。
Yonsei Med J. 2006 Jun 30;47(3):333-42. doi: 10.3349/ymj.2006.47.3.333.
3
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.通过原位逆转录聚合酶链反应(In Situ-RT-PCR)在细胞培养和石蜡包埋的人乳腺癌细胞系异种移植模型中进行基质金属蛋白酶(MMP)基因表达的体外和体内定位。
BMC Cancer. 2006 Jan 24;6:18. doi: 10.1186/1471-2407-6-18.
4
Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.I型胶原诱导的膜型1-基质金属蛋白酶表达及基质金属蛋白酶-2激活在乳腺癌转移进展中的意义
Lab Invest. 1997 May;76(5):651-60.
5
Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.成纤维细胞生长因子受体 4 通过将成纤维细胞生长因子信号传递到细胞外基质降解来调节肿瘤侵袭。
Cancer Res. 2010 Oct 15;70(20):7851-61. doi: 10.1158/0008-5472.CAN-10-1223. Epub 2010 Sep 28.
6
Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.膜型1基质金属蛋白酶的表达受紧密连接蛋白-1在人乳腺癌细胞中的调控。
Cancer Res. 2005 Sep 1;65(17):7691-8. doi: 10.1158/0008-5472.CAN-04-4230.
7
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.沉默 MCF10DCIS.com 细胞中的 HSulf-2 表达可减弱体内导管原位癌向浸润性导管癌的进展。
Breast Cancer Res. 2012 Mar 12;14(2):R43. doi: 10.1186/bcr3140.
8
Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.金属蛋白酶MMP-9和MT1-MMP在CXCL12促进骨髓瘤细胞跨基底膜侵袭中的作用。
J Pathol. 2006 Jan;208(1):108-18. doi: 10.1002/path.1876.
9
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.转移抑制因子 NME1 通过调控 MT1-MMP 表面清除来控制乳腺癌的浸润开关。
Oncogene. 2021 Jun;40(23):4019-4032. doi: 10.1038/s41388-021-01826-1. Epub 2021 May 19.
10
Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.表皮调节素通过调节基质金属蛋白酶1并促进细胞存活来促进乳腺肿瘤发生。
Mol Cancer. 2015 Jul 29;14:138. doi: 10.1186/s12943-015-0408-z.

引用本文的文献

1
MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer.基质金属蛋白酶14(MMP14)和盘状结构域受体2(DDR2)是转移性三阴性乳腺癌的潜在分子标志物。
Sci Rep. 2025 Jul 1;15(1):21630. doi: 10.1038/s41598-025-05538-4.
2
VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis.VPS35/Retromer依赖的MT1-MMP调控促进黑色素瘤转移。
Sci China Life Sci. 2025 May 8. doi: 10.1007/s11427-024-2884-2.
3
The Microenvironment in DCIS and Its Role in Disease Progression.导管原位癌中的微环境及其在疾病进展中的作用。

本文引用的文献

1
ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.ΔNp63通过增强Fzd7表达和Wnt信号传导促进乳腺发育和基底样乳腺癌中的干细胞活性。
Nat Cell Biol. 2014 Oct;16(10):1004-15, 1-13. doi: 10.1038/ncb3040. Epub 2014 Sep 21.
2
Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia.内体WASH和外排体复合物控制侵袭伪足处MT1-MMP的胞吐作用。
J Cell Biol. 2013 Dec 23;203(6):1063-79. doi: 10.1083/jcb.201306162.
3
Collective invasion in breast cancer requires a conserved basal epithelial program.
Adv Exp Med Biol. 2025;1464:211-235. doi: 10.1007/978-3-031-70875-6_12.
4
RSK3 switches cell fate: from stress-induced senescence to malignant progression.RSK3 转换细胞命运:从应激诱导的衰老到恶性进展。
J Exp Clin Cancer Res. 2023 Nov 27;42(1):318. doi: 10.1186/s13046-023-02909-5.
5
A mechanosensitive caveolae-invadosome interplay drives matrix remodelling for cancer cell invasion.机械敏感性质膜微囊泡侵入小体相互作用驱动基质重塑以促进癌细胞侵袭。
Nat Cell Biol. 2023 Dec;25(12):1787-1803. doi: 10.1038/s41556-023-01272-z. Epub 2023 Oct 30.
6
p63: a crucial player in epithelial stemness regulation.p63:上皮干细胞调节中的关键因子。
Oncogene. 2023 Nov;42(46):3371-3384. doi: 10.1038/s41388-023-02859-4. Epub 2023 Oct 17.
7
Mechanisms of action of NME metastasis suppressors - a family affair.新型肿瘤转移抑制因子作用机制 - 家族事务。
Cancer Metastasis Rev. 2023 Dec;42(4):1155-1167. doi: 10.1007/s10555-023-10118-x. Epub 2023 Jun 24.
8
Matrix metalloproteinases as therapeutic targets in breast cancer.基质金属蛋白酶作为乳腺癌的治疗靶点
Front Oncol. 2023 Jan 19;12:1108695. doi: 10.3389/fonc.2022.1108695. eCollection 2022.
9
Exploring the Integrated Role of AKT2, CD44v6, And MT1-MMP as Predictors of Axillary Lymph Node Metastasis in Invasive Breast Carcinoma of No Special Type.探索AKT2、CD44v6和MT1-MMP在非特殊类型浸润性乳腺癌腋窝淋巴结转移预测中的综合作用。
Iran J Pathol. 2022 Fall;17(4):480-490. doi: 10.30699/IJP.2022.551244.2866. Epub 2022 Oct 5.
10
Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging.抗膜型1基质金属蛋白酶纳米抗体作为三阴性乳腺癌成像免疫正电子发射断层显像探针的研发
Front Med (Lausanne). 2022 Nov 24;9:1058455. doi: 10.3389/fmed.2022.1058455. eCollection 2022.
乳腺癌的群体侵袭需要一个保守的基底上皮程序。
Cell. 2013 Dec 19;155(7):1639-51. doi: 10.1016/j.cell.2013.11.029. Epub 2013 Dec 12.
4
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.三阴性乳腺癌亚型治疗策略中生物标志物的鉴定和应用。
J Pathol. 2014 Jan;232(2):142-50. doi: 10.1002/path.4280.
5
Progression from ductal carcinoma in situ to invasive breast cancer: revisited.从导管原位癌到浸润性乳腺癌的进展:再探讨。
Mol Oncol. 2013 Oct;7(5):859-69. doi: 10.1016/j.molonc.2013.07.005. Epub 2013 Jul 12.
6
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.p63 可减弱实验性前列腺细胞模型中的上皮到间充质潜能。
PLoS One. 2013 May 1;8(5):e62547. doi: 10.1371/journal.pone.0062547. Print 2013.
7
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.粉刺型导管原位癌是基底样乳腺癌的前驱病变:一种新的p63/Her2/neu表达亚组的鉴定。
Oncotarget. 2013 Feb;4(2):231-41. doi: 10.18632/oncotarget.818.
8
ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.ΔNp63α 介导的骨形态发生蛋白信号激活调控正常和恶性乳腺上皮细胞中的干细胞活性和可塑性。
Cancer Res. 2013 Jan 15;73(2):1020-30. doi: 10.1158/0008-5472.CAN-12-2862. Epub 2012 Dec 14.
9
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.免疫组化定义的 luminal A 型乳腺癌中孕激素受体阳性肿瘤细胞的预后意义。
J Clin Oncol. 2013 Jan 10;31(2):203-9. doi: 10.1200/JCO.2012.43.4134. Epub 2012 Dec 10.
10
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.p63 及其 microRNA-205 靶基因的缺失导致前列腺癌中细胞迁移和转移的增强。
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15312-7. doi: 10.1073/pnas.1110977109. Epub 2012 Sep 4.